Central Virginia

The UVA Licensing & Ventures Group helps discoveries reach their full potential in the marketplace. In 2018 there were 213 invention disclosures filed, 59 U.S. patents issued and 77 transactions with commercial partners. 

PsiKick is utilizing revolutionary ultra-low-power technologies from the Universities of Virginia and Michigan to build completely self-powered sensing systems that do not require batteries, can be deployed nearly anywhere, and unlock new data stream

UVA Professor Shawn Russell helps those with disabilities take on skiing, proving that biomechanics research has real-life applications that can change lives for the better in Virginia and beyond.

A WMRA podcast alludes to UVA's role in the biotechnology industry in Central Virginia.

Insulin delivery technology developed at UVA and commercialized by TypeZero Technologies, Inc. received initial support from UVA's Licensing and Ventures Group (LVG).

The UVA Licensing & Ventures Group (LVG) has invested in three Charlottesville-based ventures that grew out of University research. TypeZero Technologies Inc., TearSolutions Inc., and Mission Secure Inc.

Women engineers at UVA host high school women each year to promote STEM and engineering as an accessible career path.

Albemarle County, Perrone Robotics, Inc., and Jaunt, Inc. announced a partnership that will develop, test, and operate an autonomous transit shuttle service pilot beginning in March of 2019.

Plans are underway to create ease of connection between UVA's Research Park, CHO, and the Hollymead Town Center to benefit Virginia visitors and businesses.

UVA's Center for Transportation Studies hired its first Safety Circuit Rider Engineer to fully deploy its Safety Circuit Rider Program.

The CvilleBioHub invites the biotechnology community to a reception with next generation scientists enrolled in UVA's Biotechnology Training Program.

UVA's Center for Transportation Studies hired its first Safety Circuit Rider Engineer to fully deploy its Safety Circuit Rider Program.